Actively Recruiting
Congenital CYtoMEgalovirus Infection in VIEtnam (CYMEVIE)
Led by Hanoi Obstetrics and Gynecology Hospital · Updated on 2024-03-01
5000
Participants Needed
1
Research Sites
217 weeks
Total Duration
On this page
Sponsors
H
Hanoi Obstetrics and Gynecology Hospital
Lead Sponsor
H
Hôpital Necker-Enfants Malades
Collaborating Sponsor
AI-Summary
What this Trial Is About
To estimate the prevalence of congenital CMV infection in Vietnamese neonates and relating morbidity within 2-year follow-up. Along with evaluating the predictive value of the presence and the level of CMV replication in the first trimester in a highly seropositive population
CONDITIONS
Official Title
Congenital CYtoMEgalovirus Infection in VIEtnam (CYMEVIE)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Vietnamese pregnant women in the first trimester of pregnancy and at delivery and subsequent live neonates at birth.
- Informed consent
You will not qualify if you...
- Women under 18 years old.
- Miscarriages
- Stillbirths
- Premature delivery before 34th gestational week
- Loss to follow-up maternal monitoring.
- Participation in another interventional study that influences management of labour at delivery or perinatal morbidity or mortality.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hanoi Obstetrics and Gynecology Hospital
Hanoi, Vietnam, 100000
Actively Recruiting
Research Team
H
Ha Nguyen Thi Thu, MD.PhD
CONTACT
L
Linh Dinh Thuy, MD.PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here